The global spinal implants market is expected to grow at a compound annual growth rate of 3.57% over the forecast period to reach a market size of US$15,304.985 million in 2026 from US$11,983.748 million in 2019.
Spinal implants are surgical devices that help doctors correct deformities, stabilize and strengthen the spine, and aid in fusion. Degenerative disc disease, scoliosis, kyphosis, spondylolisthesis, and fractures are some of the conditions that can be addressed with spinal implants. Biocompatible or body-friendly materials are used to create implants that provide optimal spine stability and strength. Different materials are used to make implants, including titanium, titanium alloys, stainless steel, and polymers. One of the main reasons driving the market's growth is the rising incidence of spinal diseases such as degenerative disc disease, scoliosis, kyphosis, and spondylolisthesis. This may be linked to the bulk of the working population's sedentary lifestyles and demanding schedules, which is leading to an increase in obesity, back pain, posture-related issues, and other degenerative spine diseases. Furthermore, technical advances such as the development of improved bone grafting solutions and the use of materials that are more durable than metal are boosting market expansion. Other reasons, such as the growing senior population and the expanding use of minimally invasive (MI) spinal procedures, are likely to fuel the market even further.
During the projection period, the North America region is expected to grow at a significant rate. This is due to an increase in the use of spinal implants and devices in surgery, as well as an increase in the number of procedures performed due to an older population and an increase in the prevalence of spinal diseases and impairments such as spinal stenosis. Furthermore, an increase in healthcare spending promotes implant and device sales. The Asia-Pacific area, on the other hand, is expected to expand at the quickest rate during the projection period. The expansion of the spinal implant and device market is also boosted by improvements in healthcare infrastructure and increased spending in emerging markets (such as India and China) to meet unmet medical requirements in these nations. Technological advancements for cost-effective technologies are providing a potential chance for the spinal implants and devices industry to thrive in these nations.
One of the major reasons for the growth of the global spinal implants market is the improving healthcare facilities and the growing technological advancements. Due to new technical breakthroughs, improved safety, and a better knowledge of the pathophysiology of spinal disorders, spine implants and surgeries have advanced rapidly in recent years. Advocacy for cost-effectiveness in health care services has resulted from efforts to reduce hospital costs and improve the use of limited resources. Quality and safety improvement in spine implant and surgery has been a major study priority in recent years as the modern health care system changes toward value-based care, where providers are held accountable for the quality and cost of treatments. With major knowledge gaps in the area of spine surgery causing controversy, current efforts in the worldwide spine community have resulted in the establishment of clinical practice guidelines and procedures aimed at bringing consensus to the profession. In addition, creative organizations have launched institutional-based initiatives that have shown to improve the safety of high-risk spine surgeries. All these factors have accounted to safety and larger adoption of spine surgery and implants during the forecast period which in turn fuels the demand of spine implants.
A major restraint in the growth of global spinal implants market is the cost associated with spinal implants. The costs of performing spine operations and transplants are substantial, which is a major concern for individuals with spinal abnormalities. Furthermore, strict regulatory requirements imposed by various countries are preventing players from implementing planned and inexpensive solutions for patients throughout the world. Furthermore, poor countries lack the capability of reimbursing the patient's or relative's medical and surgical expenses. All of these issues are limiting worldwide expansion for the spinal implants market.
Impact of COVID–19
The COVID-19 pandemic has had a great impact on the world as a whole and has led to economic breakdown and loss of life. The COVID-19 virus has made its way throughout the world. Furthermore, as the number of corona virus patients has increased, governments across the world have implemented a variety of regulations and lockdowns, resulting in the closure of manufacturing and production activities of firms in the spinal implant and device industry. In addition, while practitioners and surgeons focus on treating corona patients, hospitals have separately declared a decrease, delay, or cancellation of elective operations, including many orthopedic and spine cases. This break in the flow of company operations and other associated activities has a direct impact on market revenue drift. As a result, over the forecast period, the aforementioned factors are likely to restrain the growth of the spinal implant and device market. However, in the post COVID-19 scenario the market for global spinal implants will boost further with the surging demand of spinal implants across the globe. The government is investing in the construction of a large healthcare infrastructure with all of the current and modern facilities to assist people suffering from spinal difficulties and to assure their health and treatment. As the situation stabilizes, emergency spine operations and the restoration of the patient's health are being explored. Hospitals and physicians, on the other hand, are making it a point to adhere to social distance, prior appointment, and online checkups on a regular basis.
The market leaders for the pretreatment coating market are Zimmer Biomet, B. Braun Melsungen AG, Johnson & Johnson Company, NuVasive Inc., Stryker, Alphatec Spine Inc., Orthofix International N.V., RTI Surgical Inc., Globus Medical and Medtronic PLC.
|Market size value in 2019||US$11,983.748 million|
|Market size value in 2026||US$15,304.985 million|
|Growth Rate||CAGR of 3.57% from 2019 to 2026|
|Forecast Unit (Value)||USD Million|
|Segments covered||Implant Type, Surgery, End-Users, And Geography|
|Regions covered||North America, South America, Europe, Middle East and Africa, Asia Pacific|
|Companies covered||Zimmer Biomet, B. Braun Melsungen AG, Johnson & Johnson Company, NuVasive, Inc., Stryker, Alphatec Spine, Inc., Orthofix International N.V., RTI Surgical, Inc., Globus Medical, Medtronic PLC|
|Customization scope||Free report customization with purchase|
Frequently Asked Questions (FAQs)
1.1. Market Definition
1.2. Market Segmentation
2. Research Methodology
2.1. Research Data
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. The threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. Spinal Implants Market Analysis, By Type
6. Spinal Implants Market Analysis, By Surgery
6.2. Anterior Lumbar Interbody Fusion (ALIF)
6.3. Posterior Lumbar Interbody Fusion (PLIF)
6.4. Transformational Lumbar Interbody Fusion (TLIF)
6.5. Axial Lumbar Interbody Fusion (AxiaLIF)
7. Spinal Implants Market Analysis, By End-User
7.2. Hospitals & Clinics
7.3. Ambulatory Surgical Centers
8. Spinal Implants Market Analysis, By Geography
8.2. North America
8.2.1. United States
8.3. South America
8.5. The Middle East and Africa
8.5.1. Saudi Arabia
8.6. Asia Pacific
8.6.5. South Korea
9. Competitive Environment and Analysis
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix
10. Company Profiles
10.1. Zimmer Biomet
10.2. B. Braun Melsungen AG
10.3. Johnson & Johnson Company
10.4. NuVasive Inc.
10.6. Alphatec Spine Inc.
10.7. Orthofix International N.V.
10.8. RTI Surgical Inc.
10.9. Globus Medical
10.10. Medtronic PLC
B. Braun Melsungen AG
Johnson & Johnson Company
Alphatec Spine Inc.
Orthofix International N.V.
RTI Surgical Inc.
All our studies come with 2 months of analyst support.
We are in compliance with the global privacy laws.